On March 26, the House of Delegates approved legislation that would allow Maryland’s attorney general to sue pharmaceutical companies for spiking drug prices higher than is considered reasonable.
The proposed law would allow the attorney general to demand an explanation from pharmaceutical companies that increase a drug price by more than 50 percent. The attorney general will also have the authority to request a judge to determine whether a pharmaceutical company executed an “unconscionable increase” on a critical prescription drug.
The legislation passed the House on a 137-4 vote and advances to the Senate. With three weeks left in the 2017 Maryland General Assembly session, it is possible that the vote may be postponed until the next session.